14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $133.39 $156.84 Thursday, 2nd May 2024 ASND stock ended at $141.10. This is 0.0638% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.40% from a day low at $139.26 to a day high of $143.99.
90 days $133.39 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Aug 22, 2022 $92.54 $93.56 $89.21 $89.60 181 898
Aug 19, 2022 $94.37 $94.37 $92.02 $92.59 401 647
Aug 18, 2022 $96.57 $96.69 $92.65 $94.58 291 477
Aug 17, 2022 $99.88 $100.00 $96.67 $96.79 296 222
Aug 16, 2022 $107.66 $107.89 $99.26 $99.95 531 018
Aug 15, 2022 $109.07 $110.34 $106.30 $107.66 583 022
Aug 12, 2022 $105.98 $110.39 $103.29 $110.23 519 850
Aug 11, 2022 $99.21 $107.20 $95.15 $104.81 1 011 324
Aug 10, 2022 $94.25 $95.32 $91.51 $95.14 1 226 832
Aug 09, 2022 $98.36 $98.79 $92.79 $93.15 624 408
Aug 08, 2022 $95.28 $100.04 $94.96 $98.93 1 414 129
Aug 05, 2022 $90.07 $95.29 $88.90 $94.91 1 148 255
Aug 04, 2022 $89.49 $92.77 $89.05 $91.55 507 558
Aug 03, 2022 $86.96 $89.98 $86.83 $88.97 197 892
Aug 02, 2022 $83.92 $87.71 $83.92 $86.87 320 189
Aug 01, 2022 $85.08 $87.11 $83.61 $84.03 164 796
Jul 29, 2022 $86.29 $87.88 $84.84 $85.53 238 946
Jul 28, 2022 $89.28 $89.98 $85.25 $86.24 207 575
Jul 27, 2022 $87.75 $89.19 $84.94 $88.87 247 810
Jul 26, 2022 $86.30 $88.50 $85.05 $87.57 344 788
Jul 25, 2022 $89.07 $89.07 $85.10 $87.02 303 472
Jul 22, 2022 $90.14 $90.72 $87.86 $88.51 311 783
Jul 21, 2022 $90.04 $91.29 $89.58 $90.09 190 786
Jul 20, 2022 $88.32 $91.04 $86.95 $90.25 402 885
Jul 19, 2022 $87.18 $88.02 $85.50 $87.94 156 481
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT